PYXS CIK: 1782223

Pyxis Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.3
FY22:
−89.3
FY23:
−70.7
FY24:
−57.7
FY25:
−63.5
Change from FY21 to FY25
millions USD
FY21:
−0.59
FY22:
−6.40
FY23:
−105
FY24:
8.16
FY25:
58.9
Change from FY21 to FY25
millions USD
FY21:
304
FY22:
0.18
FY23:
5.93
FY24:
59.3
FY25:
0.59
millions USD
FY21:
268
FY22:
−95.6
FY23:
−170
FY24:
9.81
FY25:
−4.05
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.9
FY22:
−95.7
FY23:
−77.4
FY24:
−57.9
FY25:
−63.5

All amounts in millions USD Data source:SEC EDGAR